Swedish Orphan Biovitrum Sustainability Profile
Swedish Orphan Biovitrum AB, commonly known as Sobi, is a leading biopharmaceutical company headquartered in Sweden (SE). Founded in 1991, Sobi has established itself as a key player in the biotechnology industry, focusing on rare diseases and specialty care. With a strong operational presence across Europe, North America, and the Asia-Pacific region, Sobi is dedicated to developing innovative therapies that address unmet medical needs. Sobi's core product portfolio includes treatments for haemophilia, inflammation, and genetic disorders, distinguished by their commitment to patient-centric solutions and advanced biopharmaceutical technologies. The company has achieved significant milestones, including strategic partnerships and a robust pipeline of therapies, solidifying its market position as a trusted provider in the rare disease sector. Sobi continues to make strides in improving patient outcomes and enhancing the quality of life for those affected by complex health conditions.
DitchCarbon Score
How does Swedish Orphan Biovitrum's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Swedish Orphan Biovitrum's score of 60 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Swedish Orphan Biovitrum's reported carbon emissions
In 2024, Swedish Orphan Biovitrum (Sobi) reported total carbon emissions of approximately 253.3 million kg CO2e. This figure includes Scope 1 emissions of about 1.1 million kg CO2e, Scope 2 emissions of approximately 771,000 kg CO2e, and Scope 3 emissions of around 251.5 million kg CO2e. The previous year, 2023, Sobi's total emissions were about 195 million kg CO2e, with Scope 1 at approximately 1.1 million kg CO2e, Scope 2 at around 815,000 kg CO2e, and Scope 3 at about 193.1 million kg CO2e. Sobi has set ambitious climate commitments, aiming for net-zero emissions across both Scope 1 and Scope 2 by 2030. They have also established a near-term target to reduce absolute Scope 1 and 2 GHG emissions by 37.8% by FY2029, using FY2023 as the baseline. Additionally, Sobi is committed to ensuring that 65% of its suppliers, by spend, covering purchased goods and services and upstream transportation and distribution, will have science-based targets by FY2029. These initiatives reflect Sobi's dedication to addressing climate change and reducing its operational greenhouse gas footprint, aligning with industry standards and global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 400,000 | 000,000 | 000,000 | 000,000 | 000,000 | 000,000 | 000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 1,200,000 | 000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 000,000 | 000,000 | 000,000 | 000,000 |
| Scope 3 | - | 000,000 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 |
How Carbon Intensive is Swedish Orphan Biovitrum's Industry?
How Carbon Intensive is Swedish Orphan Biovitrum's Location?
Swedish Orphan Biovitrum's Scope 3 Categories Breakdown
Swedish Orphan Biovitrum's Scope 3 emissions, which increased by 30% last year and increased significantly since 2017, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 86% of Scope 3 emissions.
Top Scope 3 Categories
Swedish Orphan Biovitrum's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Swedish Orphan Biovitrum has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Frequently Asked Questions
Common questions about Swedish Orphan Biovitrum's sustainability data and climate commitments
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.